Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for Postoperative Cognitive Dysfunction in Elderly Patients
NCT02927522Phase 3Unknown
- Sponsor
- Renji Hospital
- Start
- Sep 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Post-operative cognitive dysfunction (POCD) and postoperative delirium (POD) comparing Donepezil Arm with Placebo Arm (2 arms). Primary endpoints: Incidence of Postoperative Cognitive Dysfunction 7 days after surgery and Incidence of Postoperative Delirium at 7 days. Status: unknown.
02
Drugs
donepezil
03
Conditions
Post-operative cognitive dysfunction (POCD)postoperative delirium (POD)
Beyond the preview
Go deeper on NCT02927522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02927522.